Information Journal Paper
APA:
Copy. (2017). Therapy of advanced nonsmall-cell lung cancer with an SN-38-anti-trop-2 drug conjugate, sacituzumab govitecan. JOURNAL OF CLINICAL ONCOLOGY, 35(24), 2790-2797. SID. https://sid.ir/paper/759153/en
Vancouver:
Copy. Therapy of advanced nonsmall-cell lung cancer with an SN-38-anti-trop-2 drug conjugate, sacituzumab govitecan. JOURNAL OF CLINICAL ONCOLOGY[Internet]. 2017;35(24):2790-2797. Available from: https://sid.ir/paper/759153/en
IEEE:
Copy, “Therapy of advanced nonsmall-cell lung cancer with an SN-38-anti-trop-2 drug conjugate, sacituzumab govitecan,” JOURNAL OF CLINICAL ONCOLOGY, vol. 35, no. 24, pp. 2790–2797, 2017, [Online]. Available: https://sid.ir/paper/759153/en